CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4351230)

Published in World J Gastroenterol on March 07, 2015

Authors

Dennis R Johnson1, Maisoun Abdelbaqui1, Maryam Tahmasbi1, Zoltan Mayer1, Hung-Wei Lee1, Mokenge P Malafa1, Domenico Coppola1

Author Affiliations

1: Dennis R Johnson, Maisoun Abdelbaqui, Maryam Tahmasbi, Domenico Coppola, Department of Anatomic Pathology, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, United States.

Articles cited by this

Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol (2008) 7.94

Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol (2003) 3.59

CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol (2003) 3.39

Cdx1 and cdx2 expression during intestinal development. Gastroenterology (2000) 3.03

An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol (1996) 2.93

Expression of Cdx-2 in the mouse embryo and placenta: possible role in patterning of the extra-embryonic membranes. Dev Dyn (1995) 2.43

A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol (1994) 2.42

Structure of the murine homeobox gene cdx-2. Expression in embryonic and adult intestinal epithelium. J Biol Chem (1994) 2.13

Homeobox gene expression in the intestinal epithelium of adult mice. J Biol Chem (1991) 2.08

New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut (2006) 2.07

CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01

The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem Cell Biol (1998) 1.63

Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol (2003) 1.59

Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol (2003) 1.57

Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol (2003) 1.50

Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett (2002) 1.45

Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol (2009) 1.22

CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications. Int J Oncol (2002) 1.16

Cdx2 determines the fate of postnatal intestinal endoderm. Development (2011) 1.10

Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Mod Pathol (2004) 1.08

Esophageal submucosal glands: structure and function. Am J Gastroenterol (1999) 1.07

Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus? Am J Surg Pathol (2012) 1.04

Immunohistochemical assessment for Cdx2 expression in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. J Clin Pathol (2010) 0.97

Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol (2003) 0.83

Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. Hum Pathol (1996) 0.83